Rachel Sanborn, M.D.

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    AstraZeneca
    Topic: 
    Advisory board, steering committee, educational moderator, funding for investigator-sponsored trial
    Date added: 
    09/26/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    EMD Serono
    Topic: 
    Advisory board
    Date added: 
    09/26/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Daiichi Sankyo
    Topic: 
    Advisory board
    Date added: 
    09/26/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Lilly Oncology
    Topic: 
    Advisory board
    Date added: 
    09/26/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Janssen Oncology
    Topic: 
    Advisory board, steering committee
    Date added: 
    09/26/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Macrogenics
    Topic: 
    Advisory board
    Date added: 
    09/26/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Sanofi Aventis
    Topic: 
    Advisory board
    Date added: 
    09/26/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Regeneron
    Topic: 
    Advisory board
    Date added: 
    09/26/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Mirati Therapeutics
    Topic: 
    Advisory board
    Date added: 
    09/26/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    GlaxoSmithKline
    Topic: 
    Advisory board
    Date added: 
    09/26/2022

Pages

Return to 2022 Seattle Multidisciplinary Thoracic Oncology Conference